A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
LOS ANGELES - ChromaDex Corporation (NASDAQ: CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) and healthy aging research, announced today that they will be participating in Renmark Financial Communications Inc.'s live Virtual Non-Deal Roadshow...
Total net sales of $19.5 million, a gross margin of 61.4% and a net loss of $1.0 million while achieving a positive Adjusted EBITDA of $0.5 million and positive operating cash flows for the three months ended September 30, 2023. LOS ANGELES - ChromaDex Corp. (NASDAQ:...
Tru Niagen® Pro 1,000mg is recommended by physicians and used by pro-athletes as it is clinically proven to boost NAD+ levels by up to 150% in as little as three weeks LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine...
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) ("the Company") a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, November 8, 2023 at 4:30 p.m. ET to discuss its financial results for the third quarter,...
The global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, ChromaDex, and the #1 selling pet supplement brand in the USA*, Zesty Paws®, debut cellular health supplement featuring ChromaDex's industry leading healthy aging...
Flow is one of the fastest-growing premium water companies in North America. Founded in 2014, Flow’s mission since day one has been to reduce environmental impacts by providing sustainably sourced naturally alkaline spring water in a recyclable and up to 75%...
This panel explores the compelling and rapidly growing world of eco-friendly consumer products. Panelists include Trent MacDonald, CFO at Flow Beverage Corp. and Marc Delcourt, Co-Founder & CEO at Global Bioenergies. This KOL Panel was recorded during the Lytham...
Else to undertake large production of Ready-to-Drink Kids' Shakes in OctoberProduction paves the way for an immediate extensive debut across leading grocery, drug, and online partners in both the US and CanadaExpecting incremental revenues starting 4Q23 into 2024...
Celebrating a significant achievement in NAD+ research, these findings contribute to the mounting evidence indicating that NR may serve as a proactive safeguard against inflammatory cytokines in healthy adults and those with inflammation-related disorders LOS ANGELES...
This study, which utilized the gold standard method of stable isotopes, reinforces that NMN cannot cross the cell membrane directly and must first be converted to NR LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide...